Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxcity in models of progranulin deficiency

ABSTRACT: Haploinsufficiency of the progranulin (PGRN) encoding gene (GRN) causes frontotemporal lobar degeneration (GRN-FTLD) and results in microglial hyperactivation, TREM2 activation, lysosomal dysfunction and TDP-43 deposition. To understand the contribution of microglial hyperactivation to pathology we used genetic and pharmacological approaches to suppress TREM2-dependent transition of microglia from a homeostatic to a disease associated state. Trem2 deficiency in Grn KO mice reduced microglia hyperactivation. To explore antibody-mediated pharmacological modulation of TREM2-dependent microglial states, we identified antagonistic TREM2 antibodies. Treatment of macrophages from GRN-FTLD patients with these antibodies led to reduced TREM2 signaling due to its enhanced shedding. Furthermore, TREM

SUBMITTER: Anika Reifschneider 

PROVIDER: S-SCDT-EMBOJ-2021-109108 | biostudies-other |

REPOSITORIES: biostudies-other